.AstraZeneca has actually shared a very early examine the efficiency of its in-house antibody-drug c...
.After introducing a phase 3 launch based on favorable midstage outcomes, iTeos and GSK are actually...
.The FDA must be actually extra available and also joint to release a surge in commendations of rare...
.It's an uncommonly hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Thera...
.Atea Pharmaceuticals' antiviral has stopped working one more COVID-19 trial, but the biotech still ...
.Neurocrine Biosciences' mental illness course pivot has actually neglected. The biotech was not abl...
.Sanofi has created an overdue entry to the radioligand gathering, paying for 100 thousand europeans...
.After F2G's 1st effort to obtain a new course of antifungal to market was derailed due to the FDA, ...
.Moderna has vowed to cut R&D costs through $1.1 billion by 2027. The choice to shrink the financ...
.Only four months after Sanofi bet $80 million in ahead of time cash on Pivot Therapeutics' losmapim...